COMPANIES
Delos Capital Partners/Delos Life Sciences funds innovation in therapeutics and medtech. The fund focuses on clinical and pre- clinical stage companies.
It has been a wonderful partnership with Henry and Delos Capital. Delos’ experience in both the US and China, as well as its vision of value creation through collaboration on advanced innovations, has been very helpful to us.
~ Jack Wang, CEO of Hemo (China) Inc.
In addition to leveraging their significant access to innovative-DNA and capital from Asia, Delos has nimbly emerged as a key player in the US Medtech-VC scene by bringing thoughtful strategic perspectives and management support to both early and late stage startups.
~ Fred Khosravi, CEO of Imperative Care Inc.
Delos is a great long-term partner to the Shifamed incubator, having invested in several of our portfolio companies. Henry and the team have been consistent in their commitment to medical innovation, even during times of great change in our industry, and we always appreciate the perspective and vision they bring to the table.
~ Amr Salahieh, CEO of Apama Medical Inc.
DELOS CAPITAL PARTNERS / DELOS LIFE SCIENCES invests in companies whose products or development programs have demonstrated the promising potentials for saving lives and enhancing the quality of patients’ life.
THERAPEUTICS
Delos Capital Partners/Delos Life Sciences seeks to fund the development and commercialization of novel treatments with the potential of improving the lives of patients, reduce costs and increase quality of care. Delos Capital is investing in the most innovative biopharmaceutical solutions to meet the needs of patients around the globe.
MEDTECH
Delos Capital Partners/Delos Life Sciences invests in companies developing devices that address unmet medical and clinical needs in the areas of interventional cardiovascular and neurological applications, ophthalmology, spine orthopedics and bariatrics.
